Building comprehensive gene panels to interrogate tumor microenvironments across different tissues of origin can be challenging. Vizgen developed the 500-gene MERSCOPE PanCancer Pathways Panel to enable the spatial transcriptomic analysis of frequently mutated genes and other genomic abnormalities common to many types of human cancers with MERFISH technology on the MERSCOPE^® Platform.